FDA Investigator Kathryn Suttling
Kathryn Suttling has conducted inspections on 84 sites in 6 countries as of 17 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
84
Last Inspection Date:
17 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Korea (Republic of),
Portugal,
Germany,
Italy,
India
FDA Investigators that have inspected at least one site in common with Kathryn Suttling:
Alan Escalona,
Allison C Hunter,
Allison M Scheck,
Andrew I Carr,
Andrew M Kupper,
Andrew R Wasko,
Anna M Brannen,
Arie R Dyk,
Bailey A Uetrecht,
Benjamin D Shuler,
Benton M Ketron,
Brandy D Brown,
Brigitte K Hofmann,
Brittany M Kershaw,
Bryan J Love,
Carlos H Ruiz,
Cassandra L Winters,
Chateryl K Washington,
Ching Jeyg Chang,
Christian L Witkovskie,
Corrine M Carter,
Craig P Seaborn,
Craig T Rybus,
Cynthia F Kleppinger, MD,
Cynthia L Rakestraw,
D'arbra R Blankenship,
Darren S Morgan,
David J Leray,
David P Moorhead,
Donna F Campbell,
Dr. Abhijit Raha, PhD,
Dr. Cj George Chang,
Eileen J Bannerman,
Elizabeth Ll Edwards,
Ethan P Stegman,
Gene R Gunn,
Genevieve E Ghand,
Geoffrey K Kilili,
Gilbert J Heidenblut,
Holly J Wilson,
Hugh M Mcclure, II,
James G Marsh,
Jason D Werne,
Javonica F Penn,
Jennifer L Jager,
Jennifer L Sheehan,
Jessica M Wooten,
Joanne M Schlossin,
John E Russell, Jr,
Jonathan A Ferguson,
Jonathan D Green,
Joseph X Kaufman,
Joshua S Hunt,
Josiah D Davis,
Karen M Cooper,
Karen M Kondas,
Karen M Montgomery (KMM),
Kathleen D Culver,
Kenneth E Felkley,
Kent A Conforti,
Krista T Ferry,
Lauren R Collins,
LCDR Angelica M Chica,
LT Melanie M Mayor, USPHS,
Luckner Jean Marie,
Malik S Qaiser,
Maney P Sturgill,
Marcia A Worley,
Marissa R Stough,
Mary B Sheets,
Matt D Suedkamp,
Matthew B Casale,
Nadeem I Chaudhry,
Phillip M Pontikos,
Pifer,
Richard W Berning,
Rosanna M Goodrich,
Roy C Stephens,
Sandra S Saniga,
Sarah M Parkinson,
Stacey A Priest,
Stephen J Kilker,
Susan M Taylor,
Talmane J Fisher,
Thomas B Smith,
Thomas J Prigge,
Thunder N Dunkijacobs,
Tracey L Harris,
Travis V Hull,
Troy A Huffman,
Victoria M Daddeo,
Wanda Y Honeyblue,
Yvette Mlacour Davis
Kathryn Suttling's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more